ArticleThoracic cancer2020

Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non-small cell lung cancer.

Ken Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.